Wall Street News Alert Highlighted Company Edgeline Holdings, Inc. (ELHI.OB) to Acquire Biotech Firm
Edgeline Holdings announced that it has reached an agreement to acquire Intertech Bio in an all stock transaction. Intertech is a newly formed biotech company with a primary focus on developing products to treat cancer, infectious diseases and other medical conditions associated with a compromised immune system. Carl A. Chase, Vice President of Edgeline Holdings, stated, “We are pleased that we have reached this tentative agreement with Intertech and will work in an expeditious manner to complete this acquisition within the next thirty days. We believe that Intertech will be a good fit in our portfolio as we continue to…